Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 557

1.

Influence of left ventricular lead location on outcomes in the COMPANION study.

Saxon LA, Olshansky B, Volosin K, Steinberg JS, Lee BK, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow MR.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):764-8. doi: 10.1111/j.1540-8167.2009.01444.x. Epub 2009 Feb 27.

PMID:
19298563
2.

Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?

Freedberg NA.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):769-72. doi: 10.1111/j.1540-8167.2009.01487.x. Epub 2009 May 4. No abstract available.

PMID:
19460075
3.

Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.

J Card Fail. 2008 Feb;14(1):9-18. doi: 10.1016/j.cardfail.2007.08.003.

PMID:
18226768
4.

Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.

Boriani G, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ; Resynchronization for the HemodYnamic Treatment for Heart Failure Management II Investigators.

Am Heart J. 2006 May;151(5):1050-8.

PMID:
16644335
5.

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.

6.

Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.

Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.

J Card Fail. 2007 Nov;13(9):769-73.

PMID:
17996827
7.

Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience.

Seidl K, Rameken M, Vater M, Senges J.

Am J Cardiovasc Drugs. 2002;2(4):219-26. Review.

PMID:
14727967
9.

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.

Circulation. 2007 Jan 16;115(2):204-12. Epub 2006 Dec 26.

10.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

11.

Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.

Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.

J Med Assoc Thai. 2007 Jul;90(7):1458-66.

PMID:
17710992
12.

Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.

Gasparini M, Galimberti P, Regoli F, Ceriotti C, Bonadies M.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1279-83.

PMID:
16403056
13.

Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.

Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.

J Am Coll Cardiol. 2005 Dec 20;46(12):2311-21.

14.

Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.

Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA.

Europace. 2009 Mar;11(3):356-63. doi: 10.1093/europace/eun375. Epub 2009 Jan 9.

PMID:
19136489
15.

Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.

Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F.

Circulation. 2006 Dec 19;114(25):2766-72. Epub 2006 Dec 11.

16.

Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.

Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, Lindenfeld J, O'Connor C, Steinberg JS, Leigh J, Yong P, Kosorok MR, Feldman AM, DeMets D, Bristow MR.

Circulation. 2009 Feb 24;119(7):969-77. doi: 10.1161/CIRCULATIONAHA.108.793273. Epub 2009 Feb 9.

17.

Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.

Foley PW, Muhyaldeen SA, Chalil S, Smith RE, Sanderson JE, Leyva F.

Europace. 2009 Apr;11(4):495-501. doi: 10.1093/europace/eup037.

PMID:
19307283
18.

Clinical and technical determinants of long-term performance of coronary sinus leads.

La Rocca V, Bertaglia E, Solimene F, Accogli M, Iuliano A, Marrazzo N, De Luca De Masi G, Scaccia A, Donnici G, Chiariello P, Turco P, De Simone A, Ciardiello C, Stabile G.

J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):40-4. doi: 10.2459/JCM.0b013e32833245df.

PMID:
19770774
19.

Robotic-enhanced biventricular resynchronization: an alternative to endovenous cardiac resynchronization therapy in chronic heart failure.

Jansens JL, Jottrand M, Preumont N, Stoupel E, de Cannière D.

Ann Thorac Surg. 2003 Aug;76(2):413-7; discussion 417.

PMID:
12902075
20.

Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.

Gasparini M, Regoli F, Ceriotti C, Galimberti P, Bragato R, De Vita S, Pini D, Andreuzzi B, Mangiavacchi M, Klersy C.

Am Heart J. 2008 Mar;155(3):507-14. doi: 10.1016/j.ahj.2007.10.028. Epub 2007 Dec 19.

PMID:
18294488

Supplemental Content

Support Center